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The Story of Organ Transplantation
By J. ENGLEBERT DUNmHY, M.D.*

THE successful transplantation of a heart from one human being to
another, by Dr. Christian Barnard of South Africa, hias occasioned an
intense renewal of public interest in organ transplantation. The background of transplantation, and its present status, with a note on certain
ethical aspects are reviewed here with the interest of the lay reader in
mind.
History of Transplants
Transplantation of tissues was performed over 5000 years ago.
Both the Egyptians and Hindus transplanted skin to replace noses
destroyed by syphilis. Between 53 B.C. and 210 A.D., both Celsus and
Galen carried out successful transplantation of tissues from one part
of the body to another. While reports of transplantation of tissues
from one person to another were also recorded, accurate documentation
of success was not established.
John Hunter, the father of scientific surgery, practiced transplantation experimentally and clinically in the 1760's. Hunter, assisted
by a dentist, transplanted teeth for distinguished ladies, usually taking
them from their unfortunate maidservants.
Modem methods for the surgical transplantation of skin from one
portion of the body to another date back to the late 1800's. At the turn
of the 19th century techniques for the transplantation of vessels and
organs were developed. The efforts of Alexander Carrel in this field
attracted much popular interest; Dr. Charles C. Guthrie, however,
should have much of the credit given to his colleague Carrel. Guthrie
transplanted a dog's head as early as 1908, and in 1912, published a
complete report describing transplantation of the heart, the lungs, the
kidneys, the thyroid, and the ovaries. These were, of course, shortterm transplants, and the survival of an organ taken from one animal to
another for long periods of time was not observed. Although Guthrie
made substantial contributions to the development of vascular surgery
and organ transplantation, Carrel's charming manner and flair for
* Professor and Chairman, Department of Surgery, University of California
School of Medicine, San Francisco.
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publicity placed him in the limelight. As a result, Carrel was awarded
the Nobel Prize for work which might well have been shared with his
associate. The first real attempt to preserve organs outside the body
came in 1938, when Carrel, in cooperation with Charles Lindberg,
developed an extracorporeal pump for human organs.
While World War II dampened the enthusiasm for organ transplantation, it nevertheless provided the setting for studies of the rejection process when transplants were made from one animal to another.
Because of the number of individuals suffering extensive injuries and
bums, the graft of skin from healthy donors to injured men was
seriously entertained. Peter Medawar and Thomas Gibson, at the
Glasgow Royal Infirmary, undertook a study of the fate of homografts
of skin used in the treatment of bums. Similar studies had been
carried out previously, most notably by Dr. Emile Holman, subsequently
a Professor of Surgery at the Stanford University Medical School in
California. Dr. Holman concluded that homografting was not a feasible
means of treating bum patients; he also deduced that the factor that
destroyed homografts was specific to the individual from whom the
graft was taken. Although the possibility of some type of immune
factor was evident, for a variety of reasons it was not pursued at that
time. Thus, it was Gibson and Medawar who first noted that when a
second set of homografts was transplanted a very rapid dissolution of
the second graft took place. Professor Medawar concluded that "the
mechanism by which foreign skin is eliminated belongs to the general
category of activity acquired immune reactions."
Since World War H a number of investigators have made elaborate
studies relative to the nature and prevention of this immune reaction.
In 1953, Medawar and two colleagues accomplished a permanent breakdown of the transplant barrier by innoculating cells into a mouse prior
to birth. Five years later, Professor F. M. Burnet, of Australia, proposed a theory to explain how a foreign protein causes cells to respond
by making antibodies that react with and reject the foreign invader.
Certain features of Bumet's theory corresponded with Medawar's earlier
findings, and in 1960, they were jointly awarded the Nobel Prize.
The Modern Era
What might be called the modem era of human kidney transplantation was ushered in at Boston's Peter Bent Brigham Hospital in the
1950's. Dr. George Thorn, a professor of medicine, had had a longstanding interest in the possibilities of kidney transplantation. In 1947,
Thorn actually initiated an attempt at transplantation which was carried
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out by Dr. Charles Hufuagel, presently Professor of Surgery at Georgetown University Medical School. This was a very dramatic case; the
transplanted kidney, which was attached to vessels in the arm, functioned
sufficiently well to enable a very ill patient to recover from a reversible
form of severe kidney failure. Although the kidney was rejected several
days after it was transplanted, its function was sufficient to tide the
patient over a crisis. The development of the artificial kidney by
Professor Kolff of Holland made this particular use of kidney transplantation unnecessary.
In the 1950's, stimulated in part by Professor Thorn, Dr. David
Hume, presently Professor of Surgery at the Medical College of Virginia,
began a series of carefully studied transplants of human kidneys. In
these transplants, no effort was made to alter the immune response. It
is of particular significance that in one patient the transplant functioned
successfully for nearly six months; the patient died almost as much from
severe vascular disease and heart failure as from renal insufficiency.
Dr. Hume's work was further developed by Dr. Joseph Murray, a graduate of Holy Cross College and the Harvard Medical School. Dr. Murray performed additional transplants in unprepared recipients; but
again no long term success could be claimed.
As the interest in homografting kidneys began to wane, an opportunity occurred to carry out a kidney transplantation between identical
twins. In December of 1954, Dr. Murray, jointly with Dr. J. Hartwell
Harrison, transplanted a kidney from a healthy twin to his brother who
was suffering from advanced kidney disease. The operation was in
every respect a complete success, and the patient was discharged from
the hospital fully recovered-so healthy that he married one of the
nurses who helped care for him. It was now clear that kidney trans:
plantation was feasible and practical; however, a means of suppressing
the immune response on the part of the recipient remained to be found.
The story is a long one. Many methods of suppressing the immune response have been and are being tried. Exposure of the whole
body to X-rays was dismissed as too dangerous for the patient. In
1959, a very important observation was made by Robert Schwartz and
William Dameshek of Tufts; certain drugs were found to have a
specific blocking effect upon immunological responses. Dr. Roy F.
Calne of England was among the first to recognize the significance of
these observations and undertook a practical resolution of the problem
in the laboratories of Dr. Joseph Murray at Harvard. Working jointly
with Dr. Murray, Dr. Calne demonstrated that successful transplantations of kidneys from one dog to another could be accomplished by
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appropriate adjustment of the dose of immunosuppressive drugs.
While the exact actions of the drugs are still not fully understood, their
suppressive effects upon the immune reaction to transplantation have
been confirmed in many laboratories and clinics. Other drugs were
later used, such as cortisone, certain antibiotics, and most recently an
immune serum that destroys the small cells known to effect rejection.
The next step in the development of organ transplantation was the
cautious application of this newly acquired knowledge to man. Once
again, the pioneer work was done in Boston by Dr. Murray and his team.
The work proceeded carefully and cautiously. Between 1960 and 1963,
hardly a dozen operations were performed. Success came slowly, but
steadily, and by 1963, it was evident that wider employment of the
operation was possible under carefully controlled clinical and laboratory
conditions. In a number of institutions, including the University of
Colorado and the University of California (Los Angeles and San Francisco), human transplantations of kidneys from one living donor to
another were undertaken. A registry of kidney transplantations was
established in which more than 2000 such operations have been recorded.
Presently, there are about a dozen major centers throughout the world
engaged in kidney transplantation, and each year the possibilites for
long term, permanent survival of the transplanted kidney are growing.
The Present State of Kidney Transplantation
At the University of California, San Francisco, Dr. John Najarian
initiated a clinical study of renal transplantation in January of 1964. Dr.
Najarian had previously spent three years in the study of immunology
and utilized this background and knowledge to establish a specific
pattern for transplantation. His results are typical of the best transplant centers in the world. The operation is done in two stages.
The patient is prepared for the first operation by treatments with
an artificial kidney until the serious effects of renal failure are corrected. Both kidneys and the spleen (an organ which produces
many of the small cells known to participate in organ rejection) are
removed during the first operation. After additional treatment on the
artificial kidney, a kidney from another person, usually a close relative,
is transplanted in a second operation. With modern technique, the new
kidney begins to function immediately and early rejection rarely occurs.
The work begun by Dr. Najarian has been continued by Dr.
Samuel Kountz and Dr. F. 0. Belzer at the University of California,
San Francisco. New methods of tissue classification have shown that
unrelated people may have kidneys of a similar type, just as unrelated
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people have blood groups of a similar type. This chance relationship
may account for the rare prolonged survival of kidney transplants to
unrelated donors before the use of immunosuppression. Skillful and
experienced use of the immunosuppressive drugs and cortisone has
almost eliminated the immediate rejection crisis, and recent data from the
University of California, San Francisco, promises initial success for as
long as one year in 90 percent of all transplants.
Despite initial success, late complications and crises still prevent the
widespread adoption of kidney transplantation. Each patient is a
special experiment requiring the most minute attention, both during the
operation and in immediate and long-term postoperative care. The use
of new radio-isotope techniques by Dr. Samuel Kountz at the University of California, San Francisco, promises to detect rejection before overt changes in renal function appear. Such detection will permit changes in immune therapy and help prevent late crises. The
specific immune serum mentioned earlier has also been used in human
transplantations, notably by Dr. Thomas Starzl. at the University of
Colorado. While the results are encouraging, the method is extremely
painful and not sufficiently established to supplant other measures.
Being a paired organ, the kidney lends itself to donation from one
person to another. The transplantation is so safe that no kidney donor
has died or suffered any serious consequences. Nevertheless, it is a
substantial sacrifice, particularly for parents donating a kidney to one of
many children. A mother has obligations not only to the child with
renal failure, but to her other healthy children. Although one kidney
will sustain life normally and indefinitely, there is the risk that disease
or injury will affect the remaining organ. The ethical questions involved in asking a minor to give a kidney to a brother or a cousin have
become so complex that it is no longer practiced in most centers.
While there is increasing interest in obtaining kidneys from the
dead, securing kidneys from cadavers and performing immediate transplantation is very difficult. The recipient must be adequately prepared
and often spends weeks in the hospital awaiting transplantation. At
the time of death, it may not be known whether the donor's kidney is
transplantable. Studies to determine the transplantability of a kidney
may be too dangerous for a patient struggling for life; and in the case
of sudden accidental death, there usually is not time for such studies.
Consequently, it is often impossible to use what might have been a very
satisfactory kidney for transplantation.
The taking of an organ from a dead person has raised a pressing
ethical issue: When is the patient dead? It has been proposed that
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death be defined as "when the brain appears to be irreversibly damaged, but while the heart is still beating." Such an interpretation would
permit the taking of organs which are living, at least as organs. Many
surgeons and other authorities object to this interpretation maintaining
that a person cannot be pronounced dead until he is "legally dead,"
namely, no respiration, no heart beat, no eye reflexes, and no electrical
activity of the heart and brain. Adhering to these criteria subjects the
kidney to a long period without oxygen which often results in damage
to the organ. For these reasons, cadaver transplants have not been
widely utilized.
The original dream of Alexis Carrel and Charles Lindberg to
develop a pump which would keep organs alive outside the body has
been pursued by many investigators. Recently, effective short term
success has been attained by Dr. F. 0. Belzer in the Department of
Surgery at the University of California, San Francisco.
The Contribution of Organ Preservation
In 1955, Dr. Stanley Jacob, working with Professor Collins of the
Massachusetts Institute of Technology, devised new methods of freezing
tissues and organs in the hope of maintaining viability. Their experiments confirmed the observations of others that thin tissues and cells
could be frozen to temperatures of -273' centigrade without injury;
however, when whole organs were frozen serious damage resulted.
Subsequently, at the University of Oregon, Dr. Jacob devised methods of
super-cooling without ice formation by placing organs in cold chambers
under pressure at temperatures well below freezing. Using this technique, Dr. Jacob kept hearts alive and functional for periods of up to
eight hours. While Jacob was experiencing some success with the supercooling method, another approach was initiated by Drs. Mark Vetto
and F. 0. Belzer at the University of Oregon. Their method was more
akin to the original concepts of Carrel and Lindbergh in that the kidney or liver was perfused with special fluids using different kinds of
pumps and oxygenators. Similar experiments were carried out by
others; but it was invariably found that after a few hours higher pressures were required to force the fluid through the isolated organ. This
resulted in hemorrhage into the organ and progressively increasing injury. This problem plagued all workers in this field, and it was generally concluded that it was not possible to preserve organs by perfusion for more than a few hours. However, Dr. Belzer continued his
studies. By eliminating all cells, using only the plasma or fluid part of
blood, and utilizing a special method of filtration and a pump which
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simulated the action of the heart, Belzer found that the isolated kidney
could be perfused experimentally for as long as three days. When the
kidney was transplanted back to the same animal, uniformly good
function was observed.
Once again, the stage was set for a cautious application of the
findings in the experimental laboratory to the treatment of patients.
Dr. Belzer worked with a patient suffering from a fatal disease affecting
the heart, kidney and other organs. Because correction of the kidney
failure restored health for only a short time, such patients were not
usually accepted for treatment by the artificial kidney or for transplantation. While the kidney condition made death imminent, the
patient's heart function was good. The possibility of receiving a kidney
which had been under perfusion for many hours was proposed to the
patient and his family, and they avidly accepted. Despite some complications that related to the patient's underlying disease, the kidney functioned immediately after transplantation and continued to do so for
many months. This carefully executed experiment clearly established
that the human kidney could function after perfusion as well as the
animal kidneys in the experimental laboratory.
Since that time, more than 40 human kidneys have been transplanted after perfusions for varying periods of time. One case involved a
young child with cancer of both kidneys. Patients with cancer are not
acceptable for either transplant or chronic dialysis. The immediate use
of a cadaver kidney was not feasible due to the time required to remove
the patient's cancerous kidneys before the transplant could be inserted.
Once again a cadaver kidney was placed upon the perfusion pump;
when the kidney was determined to be functioning properly, the patient
was scheduled for operation. After removing the diseased kidneys and
spleen from the patient, the transplant was performed with excellent
results.
Certain details of isolated organ perfusion are currently being perfected by Dr. Belzer. It will soon be possible to place cadaver kidneys
upon a portable pump that can be taken from hospital to hospital.
Under these circumstances, cadaver transplants can be performed on a
regular schedule, which will eliminate the need to have a surgical team
ready to operate upon the death of the donor. Moreover, and perhaps
most important, the use of the pump to preserve the kidney before
transplantation greatly shortens the period without blood supply and
oxygen. Further perfection of this technique will do much to resolve
the problems in heart transplantation.
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Transplantation of Other Organs
Despite the temporary success of several heart transplants, there are
many inherent difficulties in transplanting the heart which demand a
cautious approach. In contrast to the kidney, a patient has but one
heart, and to remove this heart while still beating raises obvious moral
and ethical issues. While the patient with an advanced kidney disease
may be effectively prepared for a transplant with the use of an artificial
kidney, at the present time there is no such way to prepare a prospective
heart recipient. Thus a "good heart" must be taken from a dying or
dead person and transplanted to another patient who is also dying.
A pump is needed which can adequately prepare the recipient patient
for the operation; hearts taken from patients already dead and maintained on pumps of the type developed by Dr. Belzer could then be
transplanted. It has been established that hearts can be maintained
satisfactorily on such pumps. Under these circumstances, heart transplantation could be accomplished under the same "ideal conditions"
now available for kidney transplantation. There is a growing body of
opinion that heart transplantation in humans should probably await
such developments.
Of all the organs that have been transplanted (or are likely to be
transplanted) in man, the liver, a highly complex organ with more
important functions than any other organ in the body, is the most
difficult to transplant. The liver was transplanted experimentally by
Dr. Stuart Welch of the Albany Medical School many years ago;
his work has been confirmed and extended by Dr. Thomas Starzl at the
University of Colorado and Dr. Francis D. Moore at the Peter Bent
Brigham Hospital in Boston. Dr. Starzl has carried out several liver
transplants in patients with encouraging results, particularly in children.
Although the accomplishments of Dr. Starzl have attracted far less
attention than those in heart transplantation, they represent a much
greater technical and biological accomplishment; the heart is simply a
pump, whereas the liver is an enormously complex metabolic factory
which produces sugars, proteins, enzymes, bile, and hormones. There
is scarcely a function that the human body performs in which the liver
does not participate. Its successful transplantation in the laboratory
and in man is the acme of transplantation surgery. Unfortunately, because the liver is a single, complex organ which can only be secured
after death, it is unlikely that liver transplantation will become an
established operation in man for some time to come; extensive study
and occasional transplants in man, however, will be continued by those
groups prepared to evaluate every step of the process.
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There are diseases, common among children, which seriously cripple the brain and raise the possibility of brain transplantation from
children dying from a heart or liver disease. The possibility of a
transplant of the brain staggers the imagination; but transplantation of
the brain alone is a technical impossibility. Moreover, the brain is the
most sensitive of all organs to lack of oxygen. Brain transplantation,
therefore, can only be accomplished by transplanting the head of one
living animal to another as Guthrie did experimentally many years ago.
Even if the brain lives, however, the recipient's spinal cord will be
divided creating total paralysis. The spinal cord does not regenerate
even in the intact animal, and there is no reason to expect a different
result after transplantation. This thought of beheading a person, even
a dying one, to transplant his head to another's paralyzed body raises
ethical and moral issues which override all other considerations.
Excessive publicity given to heart transplantation obscures the very
practical accomplishments of transplantation of many other tissues and
organs, particularly within the same patient. The transplantation of
skin, bones, tendons, muscles, and arteries is performed every day with
restoration of normal function to many parts of the body; and the
homotransplantation of skin is also commonly employed in the treatment of burns and large wounds. Transplants of the cornea for blindness are now well established. The transplanting of many structures
and organs from one person to another, including portions of the intestinal tract, the spleen and various endocrine glands is almost certain
to occur.
The transplantation of organs will soon be a regular clinical
accomplishment. This will be beneficial only if employed to restore
health and not to maintain life. Serious moral and ethical issues are
arising because our hedonistic and materialistic society is changing our
concept of death; like Camus we are becoming afraid of it. This fear
is reflected in the concern over capital punishment and the obsession
with heart transplantation. The heart means life; transplant the heart
and we shall live forever. But are we thinking enough about the
quality of living? Because of the fear of death, the aged are subjected
to the most extraordinary measures to maintain viability. Too many
physicians, particularly of the younger generation, cannot let a patient

die with dignity.
It is time
Organic life is
tually all men
medicine, man

men took a long hard look at the normality of death.
a constant cycle of cellular death and renewal. Evendie. Despite the extraordinary advances of scientific
as a species lives no longer today than he did before.
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Many individual men live longer, so the average duration of life has
been greatly increased; but very few men live for more than a hundred
years, and of those who do, few enjoy it. Modem society seems to have
forgotten that under certain circumstances death, far from being a
tragedy, may be a comforting release.

